Pelvic exams do not help diagnose STDs in adolescent girls, study says

July 03, 2018

WASHINGTON, DC -- A pelvic exam does not improve a physician's ability to diagnose certain sexually transmitted diseases (STDs) in adolescent female patients. That is chief among several reasons why the exam's "routine performance should be reconsidered," according to new research in Annals of Emergency Medicine.

"Sexually transmitted disease rates for adolescent women are reaching their highest recorded rate," said Cena Tejani, MD, pediatric emergency physician with Newark Beth Israel Medical Center and lead study author. "Pelvic exams lack reliability and provide very little new information when compared with other methods of diagnosis. A closer review of STD diagnosis protocol could benefit the health and well-being of adolescent women all over the country."

Among 288 patients in an observational analysis, pelvic exam results did not change the clinician's decision to treat a large majority (217 of the cases) with antibiotics. There were 79 patients with chlamydia, gonorrhea or trichomonas vaginal infections, according to positive urinalyses. The pelvic exam information did influence the case management in 71 instances, 35 of which correlated with the STD tests while 36 did not. The pelvic exam information did not consistently help the physicians better identify whether the patient was STD positive or negative, the study found.

The study, "The Additive Value of Pelvic Exams to History in Predicating Sexually Transmitted Infections for Adolescent Females with Suspected Cervicitis or Pelvic Inflammatory Disease," confirmed that pelvic exams do not increase the sensitivity or specificity of diagnosis.

Practitioners may choose to perform pelvic exams, because urine test results are not immediately available, the study authors note. Current guidelines from the Centers for Disease Control and Prevention suggest using a combination of history and physical exams, and to treat empirically based on clinical findings derived largely from pelvic examinations.

However, patients are less likely to return for follow-up appointments if they learn that a pelvic exam is part of the evaluation, according to other research cited in the study. And, the study notes that adolescents are more likely to participate in STD surveillance programs if samples are self-collected.

The study involved 288 female patients ages 14 to 20 at an urban pediatric emergency department. In 2016, there were more than 1.5 million chlamydia cases and more than 400,000 gonorrhea cases reported in the United States, a record high. Females ages 15 to 24 account for nearly two-thirds of chlamydia and half of gonorrhea diagnoses.

Patients with these infections are more likely to become infertile, have ectopic pregnancies, have dysfunctional uterine bleeding, suffer chronic pelvic pain and develop HIV infection.

"Patients that receive pelvic exams may sometimes be unaccompanied minors, and sexual health -- especially for an adolescent girl -- can be a very sensitive topic," said Dr. Tejani. "As physicians, it is important to be aware of the limitations of pelvic exam data and the impact that these invasive procedures have on some patients."

"Rapid urine STD testing provides a more accurate less invasive way to diagnose these diseases. Hospitals should strongly consider purchasing these tests to better evaluate young women with STDs," said Dr. Tejani.
-end-
Annals of Emergency Medicine is the peer-reviewed scientific journal for the American College of Emergency Physicians, the national medical society representing emergency medicine. ACEP is committed to advancing emergency care through continuing education, research, and public education. Headquartered in Dallas, Texas, ACEP has 53 chapters representing each state, as well as Puerto Rico and the District of Columbia. A Government Services Chapter represents emergency physicians employed by military branches and other government agencies. For more information, visit http://www.acep.org.

American College of Emergency Physicians

Related Chlamydia Articles from Brightsurf:

Chlamydia: Greedy for glutamine
If chlamydiae want to multiply in a human cell, the first thing they need is a lot of glutamine.

Chlamydia build their own entrance into human cells
Chlamydia, a type of pathogenic bacteria, need to penetrate human cells in order to multiply.

Targeted gene modification in animal pathogenic chlamydia
Researchers at Umeå University (Sweden), in collaboration with researchers at the University of Maryland and Duke University (USA), now for the first time successfully performed targeted gene mutation in the zoonotic pathogen Chlamydia caviae.

How Chlamydia gain access to human cells
Infection biologists at Heinrich Heine University Düsseldorf (HHU) and the University of Freiburg have found out how the LIPP protein discovered in Düsseldorf helps Chlamydia to infect human cells.

Researchers discover how chlamydia takes up new DNA from host
A recent paper by a team of molecular biologists headquartered at the University of Kansas pinpointed a gene that allows chlamydia to take up DNA from its host environment.

Chlamydia in testicular tissue linked to male infertility
The potential impact of undiagnosed sexually transmitted chlamydia infection on men's fertility has been highlighted in a study led by scientists at Queensland University of Technology (QUT), which for the first time found chlamydia in the testicular tissue biopsies of infertile men whose infertility had no identified cause.

New rapid DNA test to diagnose chlamydia infection in koalas
A new DNA test to detect chlamydia infection in koalas which gives on-the-spot results within 30 minutes has been developed in a collaboration between researchers in Brisbane, Australia.

Researchers identify how vaginal microbiome can elicit resistance to chlamydia
The vaginal microbiome is believed to protect women against Chlamydia trachomatis, the etiological agent of the most prevalent sexually transmitted infections (STIs) in developed countries.

The Lancet Infectious Diseases: First ever phase 1 trial of genital chlamydia vaccine finds it is safe and provokes immune response
The first ever chlamydia vaccine to reach phase 1 clinical trial has been found to be safe and able to provoke an immune response, according to a study published in The Lancet Infectious Diseases journal.

Last chlamydia-free koala population may safeguard future of species
The last, large, isolated, healthy chlamydia-free population of koalas in Australia may have been identified on Kangaroo Island, said Morris Animal Foundation-funded researchers at the University of Adelaide.

Read More: Chlamydia News and Chlamydia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.